Clinical Trials Logo
  1. Home
  2. Coronary Disease
  3. NCT03380286
  4. Details
NCT03380286 Clinical Trial

IRIS-Firehawk® Cohort in the IRIS-DES Registry

Coronary Disease Clinical Trial

— IRIS Firehawk  

Official title:
Evaluation of Effectiveness and Safety of Firehawk® Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study

Clinical Trial Details — Status: Withdrawn

Administrative data
NCT number NCT03380286
Other study ID # AMCCV2017-09
Secondary ID
Status Withdrawn
Phase N/A
First received December 17, 2017
Last updated March 7, 2018
Start date March 2018
Est. completion date December 2025

Study information
Verified date March 2018
Source Asan Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this study is to evaluate effectiveness and safety of Firehawk® stent in the "real world" daily practice as compared with other drug-eluting stents.

Recruitment information / eligibility
Status Withdrawn
Enrollment 0
Est. completion date December 2025
Est. primary completion date December 2021
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria:

- Age 19 and more

- Patient with Firehawk® coronary stent

Exclusion Criteria:

- Intervention with Firehawk® coronary stent and other drug eluting stent at the same time

- Life-expectancy less than 1 year

- Cardiac shock

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Firehawk
Firehawk stent

Locations
Country Name City State
Korea, Republic of Asan Medical Center Seoul

Sponsors (2)
Lead Sponsor Collaborator
Duk-Woo Park, MD CardioVascular Research Foundation, Korea

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary Composite event rate of death, non-fatal myocardial infarction (MI), or Target- Vessel Revascularization (TVR) 1 year
Secondary All cause death 5 year
Secondary Cardiac death 5 year
Secondary Myocardial Infarction 5 year
Secondary Composite event rate of death or myocardial infarction (MI) 5 year
Secondary Composite event rate of cardiac death or myocardial infarction (MI) 5 year
Secondary Target- Vessel Revascularization 5 year
Secondary Target- Lesion Revascularization 5 year
Secondary Stent thrombosis 5 year
Secondary Procedural Success rate Procedural success rate is defined as < 30% final stenosis and the absence of in-hospital event including death, Q wave myocardial infarction, urgent repeat revascularization. 5 year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Completed NCT05672862 - International Post-PCI FFR Extended Registry
Completed NCT04492423 - VerifyNow® PRUTest® Cardiovascular Population Expected Values On-Drug Study
Completed NCT01205776 - EXCEL Clinical Trial N/A
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Completed NCT00046410 - Comparison of the Risk of Stroke With On- Versus Off-Pump Coronary Artery Bypass Grafting N/A
Recruiting NCT04390672 - Multivessel TALENT N/A
Completed NCT02784873 - High Intensity Interval Training in UK Cardiac Rehabilitation Programmes N/A
Completed NCT02948517 - Time Restricted Feeding for Weight Loss and Cardio-protection N/A
Not yet recruiting NCT02895009 - Hemostatic Compression Patterns After Transradial Coronary Intervention N/A
Recruiting NCT02859480 - Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI Phase 4
Withdrawn NCT02418143 - A Study to Obtain Additional Information on the Use of CorMatrix® CanGaroo ECM® Envelope
Completed NCT02510547 - Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial Phase 4
Completed NCT02382731 - Interventions to Support Long-Term Adherence aNd Decrease Cardiovascular Events Post-Myocardial Infarction N/A
Recruiting NCT01681381 - Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization N/A
Completed NCT02248415 - Administration of Warm Blood Cardioplegia With or Without Roller Pump N/A
Recruiting NCT01207167 - Mediators of Atherosclerosis in South Asians Living in America
Completed NCT02088138 - Functional Electrical Stimulation in Cardiac Patients N/A
Completed NCT02133807 - Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis Phase 3
Completed NCT02173067 - Anesthesia With Epinephrine in Diabetes Patients is Safe and Effective N/A